CDH1 and renal cell carcinoma: Not only ART, but also artemisinin significantly diminished clonogenic growth in therapy-sensitive RCC cells by down-regulating AKT, a survival protein, and up-regulating E-cadherin, an epithelial differentiation marker [58].